Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Optobionics Corp.

This article was originally published in Start Up

Executive Summary

Implantable Devices; Artificial Retina. Optobionics is developing an artificial silicon retina that may make use of remaining viable retinal circuitry to transmit visual signals to the brain. The technology is based on microphotodiodes that are implanteed into the eye either arrayed on a small silicon chip, within a biocompatible gel sheet placed in the subretinal space, or injected under the retina mxied with a gelatinous slurry. The microphotodiodes convert light energy to electrical energy.
Advertisement

Related Content

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT036923

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel